We are live on ! Find out more
GIP

Greatmark Investment Partners Portfolio holdings

AUM $906M
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+10.16%
1 Year Est. Return
+16.08%
3 Year Est. Return
+61.99%
5 Year Est. Return
+81.88%
10 Year Est. Return
+373.56%
AUM
$276M
AUM Growth
+$14.6M
Cap. Flow
-$9.35M
Cap. Flow %
-3.39%
Top 10 Hldgs %
39.22%
Holding
122
New
8
Increased
15
Reduced
72
Closed
3

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$929K
2
AFL icon
Aflac
AFL
+$820K
3
ESV
Ensco Rowan plc
ESV
+$763K
4
JNJ icon
Johnson & Johnson
JNJ
+$722K
5
PAYX icon
Paychex
PAYX
+$673K

Sector Composition

Rank Sector Weight
1 Technology 21.75%
2 Financials 19.97%
3 Healthcare 13.75%
4 Industrials 10.66%
5 Consumer Discretionary 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUMN icon
51
Lumen
LUMN
$6.91B
$1.19M 0.43%
+71,575
New +$1.21M
UMPQ
52
DELISTED
Umpqua Holdings Corp
UMPQ
$1.12M 0.41%
53,875
-1,850
-3% -$38.2K
ESV
53
DELISTED
Ensco Rowan plc
ESV
$1.11M 0.4%
46,869
-34,412
-42% -$763K
HP icon
54
Helmerich & Payne
HP
$3.45B
$1.1M 0.4%
16,970
-75
-0.4% -$4.21K
BIIB icon
55
Biogen
BIIB
$30.8B
$1.06M 0.38%
3,335
+950
+40% +$305K
NVS icon
56
Novartis
NVS
$291B
$963K 0.35%
12,806
-826
-6% -$62.3K
TIP icon
57
iShares TIPS Bond ETF
TIP
$14.5B
$938K 0.34%
8,225
-100
-1% -$11.4K
PM icon
58
Philip Morris
PM
$291B
$886K 0.32%
8,388
-369
-4% -$39.3K
PPG icon
59
PPG Industries
PPG
$26.2B
$841K 0.3%
7,200
COR icon
60
Cencora
COR
$59.6B
$840K 0.3%
9,150
+385
+4% +$31.8K
SNV
61
DELISTED
Synovus
SNV
$816K 0.3%
17,015
-8,724
-34% -$413K
SABA
62
Saba Capital Income & Opportunities Fund II
SABA
$223M
$761K 0.28%
58,920
-3,318
-5% -$43.7K
JPT
63
DELISTED
Nuveen Preferred and Income Fund
JPT
$760K 0.28%
+30,250
New +$768K
BOND icon
64
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.48B
$742K 0.27%
7,000
-30
-0.4% -$3.19K
CLB icon
65
Core Laboratories
CLB
$515M
$739K 0.27%
6,747
-70
-1% -$6.99K
KSS icon
66
CALL
Kohl's
KSS
$2.28B
$732K 0.27%
13,500
+3,500
+35% +$161K
MO icon
67
Altria Group
MO
$114B
$722K 0.26%
10,110
-1,674
-14% -$112K
AGG icon
68
iShares Core US Aggregate Bond ETF
AGG
$138B
$646K 0.23%
5,905
-325
-5% -$35.5K
BRK.B icon
69
Berkshire Hathaway Class B
BRK.B
$1.12T
$646K 0.23%
3,260
-10
-0.3% -$1.9K
DRI icon
70
Darden Restaurants
DRI
$23.4B
$629K 0.23%
6,555
IWF icon
71
iShares Russell 1000 Growth ETF
IWF
$127B
$628K 0.23%
18,640
WBA
72
DELISTED
Walgreens Boots Alliance
WBA
$601K 0.22%
8,272
-1,750
-17% -$123K
BRK.A icon
73
Berkshire Hathaway Class A
BRK.A
$1.11T
$595K 0.22%
2
BHC icon
74
Bausch Health
BHC
$2.41B
$589K 0.21%
28,350
+2,050
+8% +$32.5K
MPC icon
75
Marathon Petroleum
MPC
$91.3B
$560K 0.2%
8,490
-420
-5% -$25.7K

Similar funds

Greatmark Investment Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Greatmark Investment Partners held 122 positions worth $276M, up 5.6% from $261M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Greatmark Investment Partners withdrew a net $9.35M in Q4 2017, closing 3 positions and reducing 72 holdings. Its most notable exit was Verizon, an estimated $249K position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Greatmark Investment Partners opened a new position in Lumen worth $1.19M.

  • Greatmark Investment Partners's largest Q4 2017 buy was Lumen: 71,575 shares worth $1.19M.
  • Greatmark Investment Partners added most to Lowe's Companies in Q4 2017, an estimated $1.87M increase.
  • Greatmark Investment Partners's biggest Q4 2017 reduction was Teva Pharmaceuticals, cutting an estimated $929K.
  • Greatmark Investment Partners fully exited Verizon in Q4 2017, selling an estimated $249K.
  • Greatmark Investment Partners's ten largest holdings make up 39% of its $276M portfolio in Q4 2017.
  • Greatmark Investment Partners opened 8 new positions and closed 3 in Q4 2017.
  • Greatmark Investment Partners's portfolio value rose 5.6% quarter-over-quarter to $276M.

Based on Greatmark Investment Partners's 13F filing for Q4 2017, filed 1 Feb 2018.